We are live on ! Find out more
AAMU

Amundi Asset Management US Portfolio holdings

AUM $131B
1-Year Est. Return 73.57%
This Fund
S&P 500
This Quarter Est. Return
+9.57%
1 Year Est. Return
+73.57%
3 Year Est. Return
+113.87%
5 Year Est. Return
+203.49%
10 Year Est. Return
AUM
$85.3B
AUM Growth
+$18.2B
Cap. Flow
+$11.7B
Cap. Flow %
13.69%
Top 10 Hldgs %
18.47%
Holding
1,697
New
71
Increased
843
Reduced
433
Closed
81

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$564M
2
AMZN icon
Amazon
AMZN
+$497M
3
VZ icon
Verizon
VZ
+$459M
4
AAPL icon
Apple
AAPL
+$414M
5
WFC icon
Wells Fargo
WFC
+$405M

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$367M
2
T icon
AT&T
T
+$157M
3
CELG
Celgene Corp
CELG
+$115M
4
HRB icon
H&R Block
HRB
+$102M
5
TIF
Tiffany & Co.
TIF
+$97.6M

Sector Composition

Rank Sector Weight
1 Technology 19.24%
2 Healthcare 14.81%
3 Financials 14.59%
4 Consumer Discretionary 12.37%
5 Industrials 9.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AROC icon
1426
Archrock
AROC
$5.8B
$176K ﹤0.01%
17,500
AWR icon
1427
American States Water
AWR
$3.46B
$173K ﹤0.01%
+2,001
New +$177K
COHR
1428
DELISTED
Coherent Inc
COHR
$173K ﹤0.01%
1,038
DNLI icon
1429
Denali Therapeutics
DNLI
$3.97B
$172K ﹤0.01%
9,900
FOLD
1430
DELISTED
Amicus Therapeutics
FOLD
$170K ﹤0.01%
17,500
SYNA icon
1431
Synaptics
SYNA
$4.15B
$170K ﹤0.01%
2,591
-1,683
-39% -$88.7K
RIG icon
1432
Transocean
RIG
$5.82B
$169K ﹤0.01%
+24,594
New +$127K
PTLA
1433
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$167K ﹤0.01%
7,000
BEAT
1434
DELISTED
BioTelemetry, Inc.
BEAT
$167K ﹤0.01%
3,600
CRVL icon
1435
CorVel
CRVL
$3.19B
$166K ﹤0.01%
5,700
ADV icon
1436
Advantage Solutions
ADV
$361M
$165K ﹤0.01%
+638
New +$163K
VSAT icon
1437
Viasat
VSAT
$11.1B
$164K ﹤0.01%
2,245
+756
+51% +$54.1K
AKCA
1438
DELISTED
Akcea Therapeutics Inc
AKCA
$164K ﹤0.01%
9,700
YELP icon
1439
Yelp
YELP
$1.41B
$161K ﹤0.01%
4,615
-2,552
-36% -$86.6K
VNOM icon
1440
Viper Energy
VNOM
$14.7B
$160K ﹤0.01%
6,500
MTZ icon
1441
MasTec
MTZ
$21.9B
$159K ﹤0.01%
2,478
AMRN
1442
Amarin Corp
AMRN
$303M
$158K ﹤0.01%
370
+45
+14% +$17.1K
DY icon
1443
Dycom Industries
DY
$12.3B
$158K ﹤0.01%
+3,345
New +$163K
ENS icon
1444
EnerSys
ENS
$6.99B
$157K ﹤0.01%
2,103
EHC icon
1445
Encompass Health
EHC
$12.4B
$156K ﹤0.01%
2,832
-3,124
-52% -$170K
TTEK icon
1446
Tetra Tech
TTEK
$9.07B
$156K ﹤0.01%
9,050
-13,640
-60% -$236K
BJ icon
1447
BJs Wholesale Club
BJ
$12.3B
$155K ﹤0.01%
+6,810
New +$168K
CASY icon
1448
Casey's General Stores
CASY
$30.9B
$155K ﹤0.01%
973
JMIA
1449
Jumia Technologies
JMIA
$767M
$155K ﹤0.01%
23,000
-209,089
-90% -$1.32M
TRTN
1450
DELISTED
Triton International Limited
TRTN
$153K ﹤0.01%
3,800

Similar funds

Amundi Asset Management US's Q4 2019 Portfolio in Review

As of Q4 2019, Amundi Asset Management US held 1,697 positions worth $85.3B, up 27% from $67B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Amundi Asset Management US deployed $11.7B of net new capital in Q4 2019, opening 71 new positions and adding to 843 existing holdings. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 1,695,000 shares worth $149M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Linde, an estimated $367M trimmed.

  • Amundi Asset Management US's largest Q4 2019 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 1,695,000 shares worth $149M.
  • Amundi Asset Management US added most to Microsoft in Q4 2019, an estimated $564M increase.
  • Amundi Asset Management US's biggest Q4 2019 reduction was Linde, cutting an estimated $367M.
  • Amundi Asset Management US fully exited Celgene Corp in Q4 2019, selling an estimated $115M.
  • Amundi Asset Management US's ten largest holdings make up 18% of its $85.3B portfolio in Q4 2019.
  • Amundi Asset Management US opened 71 new positions and closed 81 in Q4 2019.
  • Amundi Asset Management US's portfolio value rose 27% quarter-over-quarter to $85.3B.

Based on Amundi Asset Management US's 13F filing for Q4 2019, filed 14 Feb 2020.